FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280852020> ?p ?o ?g. }

• W2280852020 endingPage "17" @default.
• W2280852020 startingPage "17" @default.
• W2280852020 abstract "Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care S Pscherer,1 K Kostev,2 FW Dippel,3 W Rathmann4 1Department of Diabetology, Klinikum Traunstein, Kliniken Südostbayern AG, Traunstein, 2Epidemiology Department, IMS Health, Frankfurt, 3Sanofi-Aventis Deutschland GmbH, Berlin, 4German Diabetes Center, Institute for Biometrics and Epidemiology, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany Aim: Type 2 diabetes is associated with an increased risk of fractures. There are a few studies on the effects of diabetes treatment on fracture risk. The aim was to investigate the fracture risk related to various types of insulin therapy in primary care practices. Methods: Data from 105,960 type 2 diabetes patients from 1,072 general and internal medicine practices in Germany were retrospectively analyzed (Disease Analyzer database; 01/2000–12/2013). Fracture risk of the following therapies was compared using multivariate logistic regression models adjusting for age, sex, diabetes care, comorbidity, and glycemic control (HbAlc): 1) incident insulin therapy versus oral antidiabetic drugs, 2) basal-supported oral therapy versus supplementary insulin therapy versus conventional insulin therapy, and 3) insulin glargine versus insulin detemir versus NPH insulin. Results: There was a lower odds of having incident fractures in the oral antidiabetic drug group compared to incident insulin users, although not significant (odds ratio [OR]; 95% confidence interval: 0.87; 0.72–1.06). There were increased odds for conventional insulin therapy (OR: 1.59; 95% CI [confidence interval] 0.89–2.84) and supplementary insulin therapy (OR: 1.20; 0.63–2.27) compared to basal-supported oral therapy, which was not significant as well. Overall, there was no significant difference in fracture risk for basal insulins (glargine, detemir, NPH insulin). After a treatment duration ≥2 years, insulin glargine showed a lower odds of having ≥1 fracture compared to NPH users (OR: 0.78; 0.65–0.95) (detemir vs NPH insulin: OR: 1.03; 0.79–1.36). Conclusion: Long-standing therapy with insulin glargine was associated with a lower odds of having any fractures compared to NPH insulin. Further studies are required to investigate whether the lower chance is due to a reduced frequency of hypoglycemia. Keywords: type 2 diabetes, fracture risk, insulin treatment, oral antidiabetic medication, primary care" @default.
• W2280852020 created "2016-06-24" @default.
• W2280852020 creator A5020539103 @default.
• W2280852020 creator A5021542554 @default.
• W2280852020 creator A5053278199 @default.
• W2280852020 creator A5056713659 @default.
• W2280852020 date "2016-02-01" @default.
• W2280852020 modified "2023-09-25" @default.
• W2280852020 title "Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care" @default.
• W2280852020 cites W1966489033 @default.
• W2280852020 cites W1974609816 @default.
• W2280852020 cites W1978574536 @default.
• W2280852020 cites W1983484286 @default.
• W2280852020 cites W1986552834 @default.
• W2280852020 cites W1988666864 @default.
• W2280852020 cites W1996666687 @default.
• W2280852020 cites W2000669510 @default.
• W2280852020 cites W2008679328 @default.
• W2280852020 cites W2011753046 @default.
• W2280852020 cites W2015166879 @default.
• W2280852020 cites W2024340944 @default.
• W2280852020 cites W2032405190 @default.
• W2280852020 cites W2035136215 @default.
• W2280852020 cites W2035899311 @default.
• W2280852020 cites W2049211318 @default.
• W2280852020 cites W2061326496 @default.
• W2280852020 cites W2080030576 @default.
• W2280852020 cites W2083782926 @default.
• W2280852020 cites W2091272943 @default.
• W2280852020 cites W2093644696 @default.
• W2280852020 cites W2093954718 @default.
• W2280852020 cites W2096539888 @default.
• W2280852020 cites W2108801532 @default.
• W2280852020 cites W2119893171 @default.
• W2280852020 cites W2121414237 @default.
• W2280852020 cites W2122414041 @default.
• W2280852020 cites W2125637498 @default.
• W2280852020 cites W2131954113 @default.
• W2280852020 cites W2135881062 @default.
• W2280852020 cites W2150333580 @default.
• W2280852020 cites W2163153907 @default.
• W2280852020 cites W2399828573 @default.
• W2280852020 doi "https://doi.org/10.2147/dmso.s101370" @default.
• W2280852020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4767062" @default.
• W2280852020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26929655" @default.
• W2280852020 hasPublicationYear "2016" @default.
• W2280852020 type Work @default.
• W2280852020 sameAs 2280852020 @default.
• W2280852020 citedByCount "18" @default.
• W2280852020 countsByYear W22808520202017 @default.
• W2280852020 countsByYear W22808520202018 @default.
• W2280852020 countsByYear W22808520202019 @default.
• W2280852020 countsByYear W22808520202020 @default.
• W2280852020 countsByYear W22808520202021 @default.
• W2280852020 countsByYear W22808520202022 @default.
• W2280852020 crossrefType "journal-article" @default.
• W2280852020 hasAuthorship W2280852020A5020539103 @default.
• W2280852020 hasAuthorship W2280852020A5021542554 @default.
• W2280852020 hasAuthorship W2280852020A5053278199 @default.
• W2280852020 hasAuthorship W2280852020A5056713659 @default.
• W2280852020 hasBestOaLocation W22808520201 @default.
• W2280852020 hasConcept C126322002 @default.
• W2280852020 hasConcept C134018914 @default.
• W2280852020 hasConcept C156957248 @default.
• W2280852020 hasConcept C167135981 @default.
• W2280852020 hasConcept C2777180221 @default.
• W2280852020 hasConcept C2779306644 @default.
• W2280852020 hasConcept C2779920387 @default.
• W2280852020 hasConcept C2780473172 @default.
• W2280852020 hasConcept C44249647 @default.
• W2280852020 hasConcept C555293320 @default.
• W2280852020 hasConcept C71924100 @default.
• W2280852020 hasConceptScore W2280852020C126322002 @default.
• W2280852020 hasConceptScore W2280852020C134018914 @default.
• W2280852020 hasConceptScore W2280852020C156957248 @default.
• W2280852020 hasConceptScore W2280852020C167135981 @default.
• W2280852020 hasConceptScore W2280852020C2777180221 @default.
• W2280852020 hasConceptScore W2280852020C2779306644 @default.
• W2280852020 hasConceptScore W2280852020C2779920387 @default.
• W2280852020 hasConceptScore W2280852020C2780473172 @default.
• W2280852020 hasConceptScore W2280852020C44249647 @default.
• W2280852020 hasConceptScore W2280852020C555293320 @default.
• W2280852020 hasConceptScore W2280852020C71924100 @default.
• W2280852020 hasLocation W22808520201 @default.
• W2280852020 hasLocation W22808520202 @default.
• W2280852020 hasLocation W22808520203 @default.
• W2280852020 hasLocation W22808520204 @default.
• W2280852020 hasLocation W22808520205 @default.
• W2280852020 hasLocation W22808520206 @default.
• W2280852020 hasOpenAccess W2280852020 @default.
• W2280852020 hasPrimaryLocation W22808520201 @default.
• W2280852020 hasRelatedWork W1942780217 @default.
• W2280852020 hasRelatedWork W1967162179 @default.
• W2280852020 hasRelatedWork W2015295066 @default.
• W2280852020 hasRelatedWork W2017030704 @default.
• W2280852020 hasRelatedWork W20941350 @default.
• W2280852020 hasRelatedWork W2114514509 @default.
• W2280852020 hasRelatedWork W2263141914 @default.

• next